Korjamo Riina, Heikinheimo Oskari, Mentula Maarit
a Department of Obstetrics and Gynaecology , University of Helsinki and Helsinki University Hospital , Helsinki , Finland.
Eur J Contracept Reprod Health Care. 2018 Apr;23(2):89-96. doi: 10.1080/13625187.2018.1440385. Epub 2018 Mar 14.
To analyse the post-abortion effect of long-acting reversible contraception (LARC) plans and initiation on the risk of subsequent unwanted pregnancy and abortion.
retrospective cohort study of 666 women who underwent medical abortion between January-May 2013 at Helsinki University Hospital, Finland. Altogether 159 (23.8%) women planning post-abortion use of levonorgestrel-releasing intrauterine system (LNG-IUS) participated in a randomized study and had an opportunity to receive the LNG-IUS free-of-charge from the hospital. The other 507 (76.2%) women planned and obtained their contraception according to clinical routine. Demographics, planned contraception, and LARC initiation at the time of the index abortion were collected. Data on subsequent abortions were retrieved from the Finnish Abortion Register and electronic patient files until the end of 2014.
During the 21 months ([median], IQR 20-22) follow-up, 54(8.1%) women requested subsequent abortions. When adjusted for age, previous pregnancies, deliveries, induced abortions and gestational-age, planning LARC for post-abortion contraception failed to prevent subsequent abortion (33 abortions/360 women, 9.2%) compared to other contraceptive plans (21/306, 6.9%) (HR 1.22, 95% CI 0.68-2.17). However, verified LARC initiation decreased the abortion rate (4 abortions/177 women, 2.3%) compared to women with uncertain LARC initiation status (50/489, 10.2%) (HR 0.17, 95% CI 0.06-0.48). When adjusted for LARC initiation status, age <25 years was a risk factor for subsequent abortion (27 abortions/283 women, 9.5%) compared to women ≥25 years (27/383, 7.0%, HR1.95, 95% CI 1.04-3.67).
Initiation of LARC as part of abortion service at the time of medical abortion is an important means to prevent subsequent abortion, especially among young women.
分析长效可逆避孕(LARC)计划及起始使用对流产后意外妊娠和再次流产风险的影响。
对2013年1月至5月间在芬兰赫尔辛基大学医院接受药物流产的666名女性进行回顾性队列研究。共有159名(23.8%)计划流产后使用左炔诺孕酮宫内节育系统(LNG-IUS)的女性参与了一项随机研究,并有机会从医院免费获得LNG-IUS。另外507名(76.2%)女性按照临床常规计划并采取避孕措施。收集了人口统计学信息、计划避孕措施以及首次流产时LARC的起始使用情况。从芬兰流产登记处和电子病历中获取截至2014年底的后续流产数据。
在21个月([中位数],四分位间距20 - 22)的随访期间,54名(8.1%)女性要求再次流产。在对年龄、既往妊娠、分娩、人工流产及孕周进行校正后,与其他避孕计划(21/306,6.9%)相比,计划将LARC用于流产后避孕并不能预防后续流产(33次流产/360名女性,9.2%)(风险比1.22,95%置信区间0.68 - 2.17)。然而,与LARC起始使用状态不确定的女性(50/489,10.2%)相比,已证实起始使用LARC可降低流产率(4次流产/177名女性,2.3%)(风险比0.17,95%置信区间0.06 - 0.48)。在对LARC起始使用状态进行校正后,年龄<25岁是后续流产的一个风险因素(27次流产/283名女性,9.5%),而年龄≥25岁的女性为(27/383,7.0%,风险比1.95,95%置信区间1.04 - 3.67)。
在药物流产时将LARC作为流产服务的一部分起始使用是预防后续流产的重要手段,尤其是在年轻女性中。